
Pfizer will acquire skin specialist Excaliard Pharmaceuticals as the firm looks to further diversify its pipeline. Financial terms of the …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

